Indeed, silencing of ARID1A and ARID1B in the APL cell line NB4 impaired differentiation in response to ATRA treatment, suggesting the pivotal role of these genes in the differentiation process toward the granulocytic lineage.15, 22. This evidence concerns the gene ARID1A and acute promyelocytic leukemia.